Syntun|2024 “618” Promotion Report: The GMV during China “618” promotion reached 742.8 billion yuan, and the livestreaming platforms became a traffic booster
Golidocitinib Approved in China as First-in-class JAK1 Only Inhibitor for the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma
Bybit Launches Copy Trading Pro for Collective and Synchronized Investing, Allowing Investors to Earn Passive Income with More Consistent Returns
Diabetes Researchers in China Demonstrate Early Insulin Therapy Significant Benefits Cardiovascular Health
Growatt Showcases Extensive Product Portfolio and Receives EUPD Research Top PV Brand Awards at SNEC PV Expo 2024
SEMBWASTE LAUNCHES NEW CLOSED-LOOP PARTNERS NETWORK TO DRIVE COLLABORATION AND CIRCULAR TRANSFORMATION
